P-0117 - Gemcitabine(G)-Erlotinib(E) Versus Gemcitabine-Erlotinib-Capecitabine(C) in the First Line Treatment of Patients with Metastatic Pancreatic Cancer (MPC): Efficacy and Safety Results of a Phase IIB Randomized Study from Spanish TTD Collaborative Group
| Autor: | Manuel, Benavides, Javier, Gallego, Carmen, Guillén-Ponce, Ruth, Vera, Vega, Iranzo, Inmaculada, Alés, Sara, Arévalo, Aleydis, Pisa, Marta, Martin, Antonieta, Salud, Esther, Falcó, Alberto, Sáenz, Luis, Manzano Jose, Gema, Pulido, Joaquina, Martinez-Galán, Roberto, Pazo, Carlos, López-López, Teresa, García, Olbia, Serra, Fernández-Parra Eva, M., Antonio, Irigoyen, Enrique, Aranda |
|---|---|
| Zdroj: | In Annals of Oncology June 2014 25 Supplement 2:ii49-ii49 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|